ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,097Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 1290

$306K Total Retail Price of All Prescriptions

Rank: 357 out of 1290

714 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 714 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

3% of this provider’s 714 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 13,329 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$22 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,344 1,314 1 1
OMEPRAZOLE 692 637 2 2
LEVOTHYROXINE SODIUM 648 635 3 4
ATENOLOL 628 614 4 18
ENALAPRIL MALEATE 579 563 5 62
HYDROCHLOROTHIAZIDE 508 484 6 20
LOVASTATIN 419 393 7 45
AMLODIPINE BESYLATE 412 409 8 3
TEMAZEPAM 407 383 9 71
ALPRAZOLAM 395 337 10 47
FUROSEMIDE 334 314 11 9
METOPROLOL TARTRATE 320 308 12 7
METFORMIN HCL 291 278 13 10
ALLOPURINOL 241 234 14 60
LISINOPRIL 216 204 15 5
GLYBURIDE 198 181 R 16 87
ZOLPIDEM TARTRATE 158 148 17 15
GEMFIBROZIL 153 152 18 210
FLUOXETINE HCL 152 143 19 79
AMITRIPTYLINE HCL 148 133 R 20 97
KLOR-CON M10 147 138 21 386
OXYCODONE-ACETAMINOPHEN 141 118 S2 22 65
DOXAZOSIN MESYLATE 133 133 23 64
FINASTERIDE 130 130 24 40
JANTOVEN 127 127 25 279
DONEPEZIL HCL 123 116 26 13
RANITIDINE HCL 122 122 27 49
NIFEDIPINE ER 118 118 28 110
TRIAMTERENE-HYDROCHLOROTHIAZID 110 110 29 476
CARVEDILOL 108 87 30 12
TRAMADOL HCL 103 92 31 25
HYDROCODONE-ACETAMINOPHEN 103 79 S3 31 6
TAMSULOSIN HCL 100 100 33 11
DIGOXIN 97 97 34 51
CIPROFLOXACIN HCL 89 77 35 46
LOSARTAN POTASSIUM 86 86 36 19
PLAVIX 85 72 37 32
ISOSORBIDE MONONITRATE ER 77 77 38 58
CLOPIDOGREL 74 68 39 24
ADVAIR DISKUS 71 57 40 37
SYNTHROID 68 58 41 28
EVISTA 67 67 42 287
SERTRALINE HCL 66 59 43 36
DILTIAZEM ER 64 64 44 262
KLOR-CON M20 64 58 44 268
AFEDITAB CR 63 57 46 587
GABAPENTIN 63 62 46 8
PROAIR HFA 63 63 46 73
METOPROLOL SUCCINATE 62 62 49 14
POLYETHYLENE GLYCOL 3350 62 62 49 201
CAPTOPRIL 61 61 51 412
PANTOPRAZOLE SODIUM 61 61 51 48
CRESTOR 60 60 53 17
PAROXETINE HCL 57 56 54 84
TRIAMTERENE-HCTZ 52 52 55 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.